专利检索 ap:("Banasthali Vidyapith") AND inv:"Neetika Tripathi" 第 1 页

1.

发明授权
Mebeverine as soluble epoxide hydrolase inhibitor 有权

公开(公告)号：US11766419B2

公开(公告)日：2023-09-26

申请号：US17144471

申请日：2021-01-08

申请人： Banasthali Vidyapith

发明人： Sarvesh Paliwal , Swapnil Sharma , Neetika Tripathi , Kanika Verma , Swati Paliwal

IPC分类号： A61K31/245 , A61P3/06 , A61P9/12 , A61K9/20

CPC分类号： A61K31/245 , A61K9/20 , A61P3/06 , A61P9/12

摘要： The present invention relates to a method of using Mebeverine as an sEH inhibitor. The present invention also provides a method of treating metabolic and cardiovascular disorders using Mebeverine.

2.

发明申请
Mebeverine as soluble epoxy hydrolase inhibitor 有权

公开(公告)号：US20220218648A1

公开(公告)日：2022-07-14

申请号：US17144471

申请日：2021-01-08

申请人： Banasthali Vidyapith

发明人： Sarvesh Paliwal , Swapnil Sharma , Neetika Tripathi , Kanika Verma , Swati Paliwal

IPC分类号： A61K31/245 , A61K9/20 , A61P9/12 , A61P3/06

摘要： The present invention relates to a method of using Mebeverine as an sEH inhibitor. The present invention also provides a method of treating metabolic and cardiovascular disorders using Mebeverine.